Using the mouse model of maternal immune activation, Kim et al. (9) found that the increase of IL-17A in maternal inflammation cannot only increase the risk of developing neurodevelopmental disorders but also affect the CD4+T cells of the offspring through the changes of gut microbiota, resulting in an immune sensitization phenotype of the offspring, thereby increasing susceptibility to bacteria-induced gut inflammation. Here, IL17A is linked to neurodevelopmental disorder.